Selected article for: "drug target and molecular mechanism"
Author: Jiang, Yi; Yin, Wanchao; Xu, H. Eric
Title: RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19
  • Cord-id: dvyeg5fk
  • Document date: 2020_9_4
    • ID: dvyeg5fk
    Snippet: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly become a global pandemic. Although great efforts have been made to develop effective therapeutic interventions, only the nucleotide analog remdesivir was approved for emergency use against COVID-19. Remdesivir targets the RNA-dependent RNA polymerase (RdRp), an essential enzyme for viral RNA replication and a promising drug target for COVID-19. Recently, several structures of Rd
    Document: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly become a global pandemic. Although great efforts have been made to develop effective therapeutic interventions, only the nucleotide analog remdesivir was approved for emergency use against COVID-19. Remdesivir targets the RNA-dependent RNA polymerase (RdRp), an essential enzyme for viral RNA replication and a promising drug target for COVID-19. Recently, several structures of RdRp in complex with substrate RNA and remdesivir were reported, providing insights into the mechanisms of RNA recognition by RdRp. These structures also reveal the mechanism of RdRp inhibition by nucleotide inhibitors and offer a molecular template for the development of RdRp-targeting drugs. This review discusses the recognition mechanism of RNA and nucleotide inhibitor by RdRp, and its implication in drug discovery.

    Search related documents:
    Co phrase search for related documents
    • active core and acute respiratory syndrome: 1, 2, 3, 4, 5
    • active form and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active form and long coronavirus: 1
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and acute respiratory syndrome activity: 1, 2
    • active site and long coronavirus: 1, 2, 3
    • active site and long coronavirus genome: 1
    • active site and magnesium ion: 1
    • active triphosphate metabolite and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome activity and long coronavirus: 1
    • acute respiratory syndrome and long coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long coronavirus genome: 1, 2